Monoclonal anti-Cx43 antibodies were proven to be particularly useful in improving drug distribution in brain tumors [204], while siRNA-mediated inhibition of Cx37 has been associated with increased apoptosis rates in gastric cancer cells [205]. The gene discussed is GJA1; the disease is brain neoplasm.